CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病

Abstract

Recommended Article

2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee Primary Prevention of Sudden Cardiac Death Circadian-Regulated Cell Death in Cardiovascular Diseases Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study Systemic microvascular dysfunction in microvascular and vasospastic angina Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Metabolic Interactions and Differences between Coronary Heart Disease and Diabetes Mellitus: A Pilot Study on Biomarker Determination and Pathogenesis

Original Research2021 Mar 25;cvab100.

JOURNAL:Cardiovasc Res. Article Link

Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics

DI Swerdlow, DA Rider, A Yavari et al. Keywords: lipoprotein(a)-mediated cardiovascular disease; treatment option; RNA interference therapeutics

Full Text PDF